Your browser doesn't support javascript.
loading
Reorganization of Substance Use Treatment and Harm Reduction Services during the COVID-19 Pandemic: A Global Survey
Seyed Ramin Radfar; Cornelis A J De Jong; Ali Farhoudian; Mohsen Ebrahimi; Parnian Rafei; Mehrnoosh Vahidi; Masud Yunesian; Christos Kouimtsidis; Shalini Arunogiri; Omid Massah; Abbas Deylamizadeh; Kathleen T Brady; Anja Busse; - ISAM-PPIG Global Survey Consortium; Marc N Potenza; Hamed Ekhtiari; Alexander Mario Baldacchino.
Afiliação
  • Seyed Ramin Radfar; Integrated Substance Abuse Programs Department, University of California, Los Angeles, USA; Department of Psychiatry, Tehran University of Medical Sciences, Te
  • Cornelis A J De Jong; Radboud University, Netherlands
  • Ali Farhoudian; Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Substance Abuse and Dependence Research Center, University of Social Welfare and
  • Mohsen Ebrahimi; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Iran; Materials and Energy Research Center, Iran
  • Parnian Rafei; Department of Psychology, Faculty of Psychology and Education, University of Tehran, Iran
  • Mehrnoosh Vahidi; Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran
  • Masud Yunesian; School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Christos Kouimtsidis; Surrey and Borders Partnership NHS Foundation Trust, UK
  • Shalini Arunogiri; Turning Point, Eastern Health, Box Hill, Australia
  • Omid Massah; Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  • Abbas Deylamizadeh; Rebirth Charity Society NGO, Tehran, Iran
  • Kathleen T Brady; Medical University of South Carolina, USA
  • Anja Busse; Prevention, Treatment and Rehabilitation Section; Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime, Vienna,
  • - ISAM-PPIG Global Survey Consortium;
  • Marc N Potenza; Yale School of Medicine, Connecticut Council on Problem Gambling and Connecticut Mental Health Center, USA
  • Hamed Ekhtiari; Laureate Institute for Brain Research, Tulsa, OK, USA
  • Alexander Mario Baldacchino; University of St Andrews, UK
Preprint em Inglês | medRxiv | ID: ppmedrxiv-20199133
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
BackgroundThe COVID-19 pandemic has impacted people with substance use disorders (SUDs) worldwide and healthcare systems have reorganized their services in response to the pandemic. MethodsOne week after the announcement of the COVID-19 as a pandemic, in a global survey, 177 addiction medicine professionals described COVID-19-related health responses in their own 77 countries in terms of SUD treatment and harm reduction services. The health response is categorized around (1) managerial measures and systems, (2) logistics, (3) service providers and (4) vulnerable groups. ResultsRespondents from over 88% of countries reported that core medical and psychiatric care for SUDs had continued; however, only 56% of countries reported having had any business continuity plan, and, 37.5% of countries reported shortages of methadone or buprenorphine supplies. Participants of 41% of countries reported partial discontinuation of harm-reduction services such as needle and syringe programs and condom distribution. 57% of overdose prevention interventions and 81% of outreach services also having been negatively impacted. ConclusionsParticipants reported that SUD treatment and harm reduction services had been significantly impacted globally early during the COVID-19 pandemic. Based on our findings, we provide a series of recommendations to support countries to be prepared more efficiently for future waves or similar pandemics to 1) help policymakers generate business continuity plans, 2) maintain use of evidence-based interventions for people with SUDs, 3) be prepared for adequate medication supplies, 4) integrate harm reduction programs with other treatment modalities and 5) have specific considerations for vulnerable groups such as immigrants and refugees. HighlightsO_LICOVID-19 negatively impacted services for PWSUD globally. C_LIO_LIAddiction medicine downgraded more than other psychiatry services. C_LIO_LIBusiness continuity plan for PWSUD services reported only in about half of the countries. C_LIO_LIRefugees & migrants had more negative impact compared to other vulnerable groups. C_LIO_LIHarm reduction services discontinued partially or totally during pandemic. C_LI
Licença
cc_by
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Rct Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Experimental_studies / Estudo observacional / Rct Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...